Futura Medical (FUM)

 

FUM Share PerformanceMore

52 week high63.00 06/03/17
52 week low21.65 11/10/17
52 week change -34.25 (-56.85%)
4 week volume10,953,510 26/10/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

PDMR Dealing

RNS Number: 3695U Futura Medical PLC 23 October 2017 23 October 2017 Futura Medical plc ("Futura" or "the Company") PDMR Dealing Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology has been notified that Rachael Hawken, a person discharging managerial responsibilities ("PDMR"), has purch...

Futura reports further positive data on MED2002

Futura Medical has recently completed primary market research which indicated that more than 60% of physicians in the...

Further Positive Market Research Data for MED2002

RNS Number: 6261T Futura Medical PLC 16 October 2017 For immediate release 16 October 2017 Futura Medical plc ("Futura" or "the Company") Further Positive Market Research Data for MED2002 Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has recently completed primary ...

Directors' / PDMR Dealing and Grant of Options

RNS Number: 5653Q Futura Medical PLC 13 September 2017 13 September 2017 Futura Medical plc ("Futura" or "the Company") Directors' / PDMR Dealing and Grant of Options Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that on 12 September 2017 it granted options over a total of 1,4...

Futura net losses narrow

Futura Medical's first half net losses narrowed to 1.60m - down from 1.89m a year ago. It said this reflected the planned red...

Interim Results

RNS Number: 4354Q Futura Medical PLC 12 September 2017 For immediate release 12 September 2017 Futura Medical plc ("Futura" or "the Company") Interim Results for the six months 30 June 2017 Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce its interim results for the six...

Notification of Major Interest in Shares

RNS Number: 6081P Futura Medical PLC 01 September 2017 TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Futura Medical PLC 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer 2. Reason for the no...

CSD500: Termination of Licensing Agreement

RNS Number: 7773O Futura Medical PLC 23 August 2017 For immediate release 23 August 2017 Futura Medical plc CSD500: Notice of Termination of Licensing Agreement Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that Church & Dwight Co Inc, with which the Company signed a li...

Fundamental DataMore

EPS-3.65
Dividend yield0 %

Latest discussion posts More

  • Re: Negotiations negotiations negotiatio...

    Page 2 Common problems in negotiation 'Off-the-record' Quote 'Off-the-record' discussions should be very frequently employed to get around an impasse and to ensure ...
    21-Nov-2017
    trump53
  • Re: CSD500 availability

    "If anyone has any specific questions about asset price movement and FUM in particular I will try and answer them on ...
    21-Nov-2017
    TonyDeadeye
  • Re: Negotiations negotiations negotiations

    The cello data was most likely a request from one (or more) of the potential partners following their due diligence work so (hopefully) we'll be fairly advanced. With ...
    21-Nov-2017
    TonyDeadeye

Users' HoldingsMore

Users who hold Futura Medical also hold..
LLOYDS GRP.23%
SIRIUS MINERALS17%
BP12%
TESCO12%
BARCLAYS10%

Codes & Symbols

ISINGB0033278473
SymbolsFUM, LSE:FUM, FUM.L, FUM:LN, LON:FUM, XLON:FUM

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account